SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
OBESITY AND FATTY LIVER DISEASE
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
7 of
7
|
THEMED DISCUSSION LEADER
John R. Koethe
Vanderbilt University Medical Center, Nashville, TN, USA
BODY MASS INDEX AND THE RISK OF SERIOUS NON-AIDS EVENTS: THE D:A:D STUDY
Amit C Achhra
Kirby Institute, UNSW Australia; & NCB Hosp and JJP VA Med Ctr, New York, USA
RANDOMIZED TRIAL OF BEHAVIORAL WEIGHT LOSS FOR HIV-INFECTED PATIENTS
Katie Becofsky
University of Massachusetts Amherst, Amherst, MA, USA
Predictors of Severe Weight/Body Mass Index Gain Following Antiretroviral Initiation
Priya Bhagwat
University of California, Los Angeles, Los Angeles, CA, USA
RALTEGRAVIR SWITCH AND BIOMARKERS OF LIVER STEATOSIS AND METABOLIC SYNDROME IN WOMEN
Jordan E Lake
University Texas Houston, Houston, USA
CHANGES IN LIVER STEATOSIS AFTER SWITCHING EFAVIRENZ TO RALTEGRAVIR: THE STERAL STUDY
Juan Macías
Hospital Universitario de Valme, Sevilla, Spain
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
7 of
7
|
